Real-world Efficacy, Safety, and the Impact of Spherical Equivalent on Intravitreal Anti-VEGF Therapy in Patients Affected by Myopic Choroidal Neovascularisation
Anti-VEGF therapy in mCNV patients proved to be safe and effective in our study with sustained improvement in functional and anatomical measures. Baseline VA strongly predicted final VA, whereas baseline and final CRT showed no association. No differences in treatment outcomes were observed as based on a varying SE.
Authors
- Bernhard Stoffelns (ORCID: https://orcid.org/0000-0001-5048-3299)
- Katrin Lorenz (ORCID: https://orcid.org/0000-0002-1755-7396)
- Christina A. Korb (ORCID: https://orcid.org/0000-0001-7572-4749)
- Peter Wolfrum (ORCID: https://orcid.org/0000-0002-9694-1336)
- Anna Maria Voigt (ORCID: https://orcid.org/0009-0007-5075-7377)
Institutions
- Johannes Gutenberg University Mainz (DE)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
Publication Details
- Journal
- Klinische Monatsblätter für Augenheilkunde
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1055/a-2561-2847
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00